Novo Nordisk
kr 250.00Change from previous close: −1.26%Absolute change: −kr 3.20
At a glance
- Revenue growth
- +6.43%
- 2025 vs 2024
- Net income growth
- +1.43%
- 2025 vs 2024
- Net margin
- 33.1%
- 2024: 34.8%
Financial data
Amounts in millions of DKK; per-share values in DKK; shares in millions.
| Item | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Total revenue | 309,064 | 290,403 | 232,261 | 176,954 | 140,800 |
| Cost of revenue | 54,377 | 43,560 | 35,319 | 28,424 | 23,658 |
| Gross profit | 254,687 | 246,843 | 196,942 | 148,530 | 117,142 |
| Selling, general and administrative | 67,865 | 67,368 | 61,594 | 50,683 | 41,058 |
| Research and development | 46,159 | 40,072 | 31,075 | 23,263 | 17,199 |
| Operating income | 140,618 | 138,901 | 104,698 | 75,618 | 59,217 |
| EBIT | 140,618 | 138,901 | 104,698 | 75,618 | 59,217 |
| EBITDA | 153,295 | 145,691 | 110,736 | 81,119 | 63,770 |
| Interest expense | 4,207 | 1,640 | 542 | 378 | 289 |
| Pre-tax income | 130,540 | 127,191 | 104,674 | 69,062 | 59,080 |
| Income tax | 28,106 | 26,203 | 20,991 | 13,537 | 11,323 |
| Net income | 102,434 | 100,988 | 83,683 | 55,525 | 47,757 |
| Net income to common shareholders | 102,434 | 100,988 | 83,683 | 55,525 | 47,757 |
| Basic EPS | 23.06 | 22.67 | 18.67 | 12.26 | 10.40 |
| Diluted EPS | 23.03 | 22.63 | 18.62 | 12.22 | 10.37 |
| Average shares (basic) | 4,443 | 4,454 | 4,483 | 4,531 | 4,593 |
| Average shares (diluted) | 4,448 | 4,463 | 4,495 | 4,545 | 4,606 |
| Dividend per share | 11.70 | 11.40 | 9.40 | 6.20 | 5.20 |